Organisation paid for research Program year 2024 Source: CMS Open Payments

Victor Flores

Neither a doctor nor a teaching hospital

Research payments

$5,853,302

63 payments

Through program year 2024, Victor Flores is reported as receiving $5,853,302 in research payments, across 63 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2024	Research	$559,165	6
2023	Research	$372,356	10
2022	Research	$3,828,181	27
2021	Research	$1,093,600	20

Breakdown

Who paid Research payments · program years 2021–2024

Pfizer Inc. $5,853,302 63 payments

Studies the money was for Research payments · program years 2021–2024

A Phase 3 Study to Evaluate the Efficacy Immunogenicity and Safety of Respiratory Syncytial Virus RSV Prefusion F Subunit Vaccine in Adults $5,560,643 44 payments
An Interventional Efficacy and Safety Phase 23 Doubleblind 2Arm Study to Investigate Orally Administered Pf07321332ritonavir Compared With Placebo in Nonhospitalized Symptomatic Adult Participants With Covid19 Who Are at Increased Risk of Progressing to Severe Illness $213,788 11 payments
An Interventional Efficacy and Safety Phase 23 Doubleblind 2 Arm Study to Investigate Orally Administered PF 07321332Ritonavir Compared With Placebo in Nonhospitalized Symptomatic Adult Participants With Covid19 Who Are at Low Risk of Progressing to Severe Illness $78,871 8 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.